Leukemogenic kinase <scp>FIP</scp>1L1‐<scp>PDGFRA</scp> and a small ubiquitin‐like modifier E3 ligase, <scp>PIAS</scp>1, form a positive cross‐talk through their enzymatic activities
Makoto Ibata(Hokkaido University), Takeshi Kondo(Shinko Hospital), Daigo Hashimoto(Hokkaido University), Takanori Teshima(Hokkaido University Hospital), Masahiro Onozawa(Hokkaido University), Yoichiro Fujioka(Hokkaido University of Science), Yusuke Ohba(University of Tsukuba), Shigetsugu Hatakeyama(Hokkaido University), Junko Iwasaki(Hokkaido University), Stephanie Darmanin(Karolinska University Hospital), Koji Nakagawa(Hokkaido University)
Cited by 4
Related Papers
Expansion and Activation of CD103+ Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
|Immunity|2016|1.2k
Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1
|Nature Immunology|2012|832
Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2020|739
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
|Nature Medicine|2021|523
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
|Biology of Blood and Marrow Transplantation|2014|442